Published September 3, 2004 | Version v1
Journal article

Neuroglycan C, a novel member of the neuregulin family

  • 1. Division of Biochemistry and Molecular Biology, Department of Cellular and Molecular Genetics, Ehime University School of Medicine, Shitukawa, Shigenobu-cho, Onsen-gun, Ehime 791-0295 (Japan)
  • 2. Carna Biosciences Inc., Kobe 650-8543 (Japan)
  • 3. Department of Perinatology, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Aichi 480-0392 (Japan)
  • 4. Division of Biochemistry and Molecular Biology, Department of Cellular and Molecular Genetics, Ehime University School of Medicine, Shitukawa, Shigenobu-cho, Onsen-gun, Ehime 791-0295 (Japan) and PRESTO, JST (Japan)

Description

Neuroglycan C (NGC) is a transmembrane chondroitin sulfate proteoglycan expressed predominantly in the brain that possesses an EGF-like extracellular domain. The goal of the present study was to determine whether NGC may activate ErbB tyrosine kinases. A recombinant human NGC extracellular domain induced tyrosine phosphorylation of ErbB2 and ErbB3 as well as cell growth of the human breast tumor cell lines, T47D and MDA-MB-453. In vitro pull-down assay revealed that NGC could directly bind to a recombinant ErbB3-immunoglobulin Fc fusion protein (ErbB3-Fc) but not to ErbB1-Fc, ErbB2-Fc or ErbB4-Fc. A newly established anti-ErbB3 neutralizing monoclonal antibody (no. 5C3) almost completely blocked NGC-induced ErbB activation in MDA-MB-453 cells. Taken together, these data indicate that NGC is an active growth factor and a direct ligand for ErbB3 and that NGC transactivates ErbB2. Thus, NGC should be classified as the sixth member (neuregulin-6) of the neuregulin family

Additional details

Identifiers

DOI
10.1016/j.bbrc.2004.07.066;
PII
S0006-291X(04)01558-X;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
321
Journal Issue
4
Journal Page Range
p. 1045-1049
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.